Cathie Wood Red Hill Biopharma Ltd. Transaction History

Ark Investment Management LLC

$10.5 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	BUY	$0.63 - $2.58 $115,431 - $472,720	183,225 Added 21.26%	1,045,023 $1.17 Million
Q1 2022 Apr 19, 2022	BUY	$1.65 - $3.12 $1.42 Million - $2.69 Million	861,798 New	861,798 $2.17 Million
Q4 2021 Jan 28, 2022	SELL	$2.31 - $5.85 $44,194 - $111,922	-19,132 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$4.55 - $10.36 $3.5 Million - $7.96 Million	-768,337 Reduced 97.57%	19,132 $88,000
Q2 2021 Aug 05, 2021	BUY	$5.98 - $7.51 $70,390 - $88,400	11,771 Added 1.52%	787,469 $5.42 Million
Q1 2021 May 13, 2021	BUY	$6.98 - $11.29 $4.25 Million - $6.88 Million	608,949 Added 365.19%	775,698 $5.68 Million
Q4 2020 Feb 12, 2021	BUY	$7.81 - $10.39 $342,773 - $456,006	43,889 Added 35.72%	166,749 $1.35 Million
Q3 2020 Oct 30, 2020	SELL	$6.34 - $10.83 $147,734 - $252,360	-23,302 Reduced 15.94%	122,860 $1.26 Million
Q2 2020 Aug 11, 2020	BUY	$4.6 - $8.6 $230,050 - $430,094	50,011 Added 52.01%	146,162 $979,000
Q1 2020 May 14, 2020	BUY	$3.51 - $6.17 $132,600 - $233,090	37,778 Added 64.72%	96,151 $436,000
Q4 2019 Jan 31, 2020	BUY	$5.76 - $7.35 $14,325 - $18,279	2,487 Added 4.45%	58,373 $354,000
Q3 2019 Nov 12, 2019	SELL	$6.46 - $8.37 $25,413 - $32,927	-3,934 Reduced 6.58%	55,886 $393,000
Q2 2019 Jul 30, 2019	SELL	$6.34 - $8.8 $38,661 - $53,662	-6,098 Reduced 9.25%	59,820 $389,000
Q1 2019 May 13, 2019	BUY	$6.06 - $9.0 $31,372 - $46,593	5,177 Added 8.52%	65,918 $548,000
Q4 2018 Feb 01, 2019	BUY	$5.18 - $9.35 $60,191 - $108,647	11,620 Added 23.66%	60,741 $337,000
Q3 2018 Nov 07, 2018	SELL	$6.0 - $11.35 $381,162 - $721,031	-63,527 Reduced 56.39%	49,121 $434,000
Q2 2018 Aug 07, 2018	BUY	$4.82 - $8.53 $42,869 - $75,865	8,894 Added 8.57%	112,648 $961,000
Q1 2018 May 14, 2018	BUY	$4.96 - $6.84 $370,581 - $511,043	74,714 Added 257.28%	103,754 $534,000
Q4 2017 Feb 12, 2018	BUY	$4.58 - $10.81 $133,003 - $313,922	29,040	29,040 $149,000

Others Institutions Holding RDHL

# of Institutions

Shares Held

40.4K

Call Options Held

Put Options Held

Eaton Vance Management Boston, MA

40.4K
Shares

$294,639
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About RedHill Biopharma Ltd.

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

More about RDHL

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account